首页 > 市场调查报告书 > 医疗设备

生技设备

市场调查报告书

商品编码

1561043

微射流市场规模、份额、成长分析、按产品、按材料、按应用、按最终用户、按地区 - 行业预测，2024-2031 年

Microfluidics Market Size, Share, Growth Analysis, By Product, By Material, By Application, By End User, By Region - Industry Forecast 2024-2031

出版日期: 2024年09月18日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年微射流的全球市场规模为217亿美元，从2023年的244.8亿美元增长到2031年的641.6亿美元，在预测期内（2024-2031年）预计复合年增长率为12.8%。

与传统流体测量装置相比，微流体系统提高了参数控制和资料质量，同时需要更少的样品和更小的设备。因此，它广泛应用于 PCR 扩增、细胞分离和 DNA 分析等应用。各种健康挑战推动了对这些技术的需求不断增长。例如，PLOS One 1 月发表的一项研究预测，到 2025 年，法国将有约 280 万慢性阻塞性肺病(COPD) 病例。预计这将重振使用微流体晶片和小血样的慢性阻塞性肺病检测市场。同样，澳洲痴呆症协会 2022 年的资料显示，当年有 487,500 名澳洲人患有失智症，预计到 2058 年这一数字将增至 110 万人。随着失智症率的上升，对有效药物发现、筛检方法和毒理学研究的需求日益增加。微流体系统可以透过促进骨骼、神经胶质和内皮细胞的发育并维持肌肉细胞的流体隔离来支持这些努力，同时能够研究器官发育和疾病机制。微流体设备在各种研究和诊断领域的使用越来越多，预计将推动市场成长。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市集活动
主要企业市场占有率（2023年）

主要企业简介

Thermo Fisher Scientific（US）
Becton, Dickinson, and Company（US）
Agilent Technologies（US）
Bio-Rad Laboratories（US）
F. Hoffmann-La Roche（Switzerland）
Danaher Corporation（US）
Illumina Inc.（US）
Fluidigm Corporation（US）
Abbott Laboratories（US）
BioMerieux（France）
Hologic（US）
Quidel Corporation（US）
SMC Corporation（Japan）
Parker-Hannifin Corporation（US）
IDEX Corporation（US）
Fortive Corporation（US）
Aignep SpA（Italy）
Dolomite Microfluidics（UK）
Elveflow（France）
uFluidix（Canada）
NanoString Technologies（US）
Nortis Inc.（US）
Innovative Biochips, LLC（US）
Fluidic Analytics（UK）

简介目录

Product Code: SQMIG35A2288

Global Microfluidics Market size was valued at USD 21.70 billion in 2022 and is poised to grow from USD 24.48 billion in 2023 to USD 64.16 billion by 2031, growing at a CAGR of 12.8% during the forecast period (2024-2031).

Microfluidic systems offer enhanced parameter control and data quality while requiring fewer samples and smaller instruments compared to traditional fluid measuring equipment. As a result, they are widely used in applications such as PCR amplification, cell separation, and DNA analysis. The growing demand for these technologies is driven by various health challenges. For instance, a study published in PLOS One in January predicts that France will have approximately 2.8 million cases of chronic obstructive pulmonary disease (COPD) by 2025. This is expected to boost the market for COPD testing through microfluidic chips and small blood samples. Similarly, data from Dementia Australia in 2022 shows that 487,500 Australians were living with dementia in that year, and the number is forecasted to increase to 1.1 million by 2058. With rising dementia rates, there is an increasing need for efficient drug discovery, screening methods, and toxicology studies. Microfluidic systems can support these efforts by facilitating the development of skeletal, glial, and endothelial cells, enabling research into organ development and disease mechanisms while maintaining fluid isolation of muscle cells. The expanding use of microfluidic devices across various research and diagnostic fields is expected to drive market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Microfluidics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Microfluidics Market Segmental Analysis

Global Microfluidics Market is segmented by Product, Material, application, end user and region. Based on Product, the market is segmented into Microfluidics-based Device, Microfluidic Components. Based on Material, the market is segmented into Glass, Silicon, Polymer, and Others. Based on Application, the market is segmented into In Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing, Therapeutics. Based on End User, the market is segmented into Hospital and Diagnostic Centers, Academic and Research Institute, Pharmaceutical & Biotechnology Companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Drivers of the Global Microfluidics Market

The adoption of microfluidic devices in personalized medicine is on the rise due to their capacity to deliver high-throughput and high-quality results. As personalized medicine continues to gain traction, the demand for microfluidic devices is expected to grow accordingly. These devices are particularly well-suited for point-of-care diagnostics, offering portability, affordability, and the ability to work with minimal sample volumes. With the increasing need for quick and accurate diagnostic tests, the use of microfluidic devices is projected to expand significantly, making them a crucial tool in modern healthcare diagnostics.

Restraints in the Global Microfluidics Market

The production of microfluidic devices involves intricate manufacturing processes that demand a high level of precision and specialized expertise. Due to the complexity involved, achieving consistent quality and performance can be challenging, making the development of these devices a highly technical endeavor. As a result, scaling up production while maintaining cost efficiency becomes difficult for companies in this sector. The need for precise fabrication techniques often leads to higher manufacturing costs, posing a barrier to reducing prices and expanding market accessibility.

Market Trends of the Global Microfluidics Market

Point-of-care testing (POCT) involves conducting medical diagnostic tests outside traditional clinical laboratories, such as in doctor's offices, hospital rooms, or even at home. Its popularity is rising due to the convenience and rapid results it provides, making it an attractive option for both patients and healthcare providers. Microfluidic devices are particularly well-suited for POCT because of their efficiency and portability. As the demand for faster and more accessible testing grows, so does the need for microfluidic devices designed for point-of-care applications.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Pricing Analysis
Value Chain Analysis
Ecosystem of the Market
Trade Analysis
Supply chain Analysis
Case study Analysis
Patent Analysis
Customer & Buying Criteria Analysis
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Degree of Competition

Microfluidics Market by Product

Market Overview
Microfluidics-based Device
Microfluidic Components
- Microfluidic Chip
- Flow And Pressure Sensors
- Flow And Pressure Controllers
- Micropumps
- Microfluidic Valves
- Microneedles
- Other Components

Microfluidics Market by Material

Market Overview
Glass
Silicon
Polymer
Others

Microfluidics Market by Application

Market Overview
In Vitro Diagnostics
- Clinical Diagnostics
- Point of Care Testing
- Veterinary Diagnostics
Pharmaceutical & Life Science Research and Manufacturing
- Lab Analytics
- Proteomic analysis
- Genomic analysis
- Cell-based assays
- Capillary electrophoresis
- Microdispensing
- Microreaction
Therapeutics
- Drug Delivery
- Wearable Devices

Microfluidics Market by End-user

Market Overview
Hospital and Diagnostic Centers
Academic and Research Institute
Pharmaceutical & Biotechnology Companies

Microfluidics Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Thermo Fisher Scientific (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson, and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fluidigm Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioMerieux (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quidel Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SMC Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Parker-Hannifin Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IDEX Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fortive Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aignep S.p.A (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dolomite Microfluidics (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Elveflow (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
uFluidix (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NanoString Technologies (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nortis Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Innovative Biochips, LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fluidic Analytics (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments